首页> 美国卫生研究院文献>Biochemical Journal >Drug-binding properties of rat alpha 1-foetoprotein. Binding of warfarin phenylbutazone azapropazone diazepam digitoxin and cholic acid.
【2h】

Drug-binding properties of rat alpha 1-foetoprotein. Binding of warfarin phenylbutazone azapropazone diazepam digitoxin and cholic acid.

机译:大鼠α1-叶蛋白的药物结合特性。华法林苯丁氮酮氮杂丙氮酮地西epa洋地黄毒苷和胆酸的结合。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

As part of an investigation into whether alpha 1-foetoprotein (alpha 1-FP) plays the same transport role in foetal serum as albumin does in the adult, the binding properties of both proteins were compared with respect to the binding of a series of compounds known to be bound by albumin's specific drug-binding sites. The binding of warfarin, phenylbutazone, azapropazone, diazepam, digitoxin and cholic acid by rat alpha 1-FP and serum albumin was studied by equilibrium dialysis at 4 degrees C. Rat alpha 1-FP was shown to have neither albumin's high-affinity site II (diazepam as marker) nor its site III (digitoxin and cholic acid as markers). High-affinity binding by alpha 1-FP was found for the specific markers (warfarin, phenylbutazone, azapropazone) of albumin's drug-binding site I. However, instead of albumin's one high-affinity site/molecule, a mean value of 0.5 site/molecule was obtained with rat alpha 1-FP. Charcoal treatment at neutral pH of rat serum albumin did not affect its measured binding properties, but treatment of the alpha 1-FP led to an increased affinity for warfarin, phenylbutazone and azapropazone without a change in the measured number of sites, indicating competition for binding at this site by (an) endogenous ligand(s). These results are discussed in terms of the structures of the two proteins and with respect to the physiological implications of the differences found.
机译:作为研究α1-foetoprotein(α1-FP)在胎儿血清中是否与成人中的白蛋白具有相同的转运作用的一部分,比较了这两种蛋白的结合特性以及一系列化合物的结合情况已知由白蛋白的特定药物结合位点结合。在4℃下通过平衡透析研究了大鼠α1-FP和血清白蛋白与华法林,苯基丁氮酮,氮杂丙氮酮,地西epa,洋地黄毒苷和胆酸的结合。显示大鼠α1-FP没有白蛋白的高亲和力位点II (地西p为标记物)或其第III位(洋地黄毒和胆酸为标记物)。发现白蛋白的药物结合位点I的特定标记(华法林,苯基丁氮酮,氮杂丙氮酮)通过alpha 1-FP具有高亲和力结合。但是,代替白蛋白的一个高亲和力位点/分子,平均值为0.5个位点/用大鼠α1-FP获得分子。在中性pH的大鼠血清白蛋白上进行炭处理不会影响其测得的结合特性,但是对α1-FP的处理导致对华法林,苯基丁氮酮和氮杂丙氮酮的亲和力增加,而测得的位点数却没有变化,表明竞争结合在该位点由一个或多个内源性配体组成。这些结果将根据两种蛋白质的结构以及所发现差异的生理意义进行讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号